期刊文献+

COL8A1 siRNA对肝癌细胞体外增殖、侵袭能力及右旋柠烯药敏性的影响 被引量:1

Effects of COL8A1 siRNA on the proliferation, invasion and drug sensitivity to D-limonence treatment in hepatocarcinoma cells
原文传递
导出
摘要 目的应用RNA干扰技术下调小鼠肝癌细胞株(Hca—F)COL8A1的表达,通过观察癌细胞的体外增殖、侵袭能力,研究调节COL8A1表达对肿瘤细胞药敏性的影响。方法采用RT-PCR、WesternBlot分析干扰前后Hca-F细胞中COL8A1的表达情况。用体外侵袭实验检测干扰前后Hca-F细胞的侵袭能力。用MTT法分析干扰前后Hca—F细胞的增殖情况及其对右旋柠烯(D-limonene)的药敏性。结果Hca-F/RNAi细胞中COL8A1的表达与未给予RNA干扰处理的对照组及RNA干扰对照组相比出现明显下调;该细胞的增殖及穿过基质胶的侵袭能力下降;同时上调该细胞对D-limonene的药敏性。结论小鼠肝癌细胞中COL8A1的表达与肿瘤细胞的增殖、侵袭及对抗肿瘤药物的敏感性密切相关,可能为肿瘤的化学治疗提供新靶点。 Objective To investigate the possible effects of COL8A1 on the proliferation, invasion and drug sensitivity of murine hepatocarcinoma cell line Hca-F, we used an RNA interference (RNAi) approach to silence COL8A1 expression. Methods The expression levels of COLSA1 in Hca- F/siRNA cells were assessed by RT-PCR and Western blot. The inhibitory effect of RNAi on Hca-F cell invasion in vitro was demonstrated by ECM invasion assay. The in vitro proliferative ability and drug sensitivity of COL8Al-deficient cells were determined by MTT assay. Results The expression of COLSA1 was significantly reduced in COL8A1/siRNA ceils after 30h transfection, compared with both the RNAi control and the Hca-F ceils. The reduced COLSA1 expression also attenuated the proliferative, invasive ability, as well as increased drug sensitivity of Hca-F/siRNA ceils. Conclusion Our current results indicate that the expression of COL8A1 functionally mediates tumor cell proliferation, invasion, and drug sensitivity, and is a potential target for therapeutic anti-cancer drugs.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2011年第3期239-242,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 COL8A1 RNA干扰 肝癌 右旋拧稀 COL8A1 RNA interference Hepatocarcinoma D-limonence
  • 相关文献

参考文献8

  • 1Shariff MI, Cox IJ, Gomaa AI, et al. Hepatocellular carcinoma:current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol, 2009,3 : 353-367.
  • 2Mirici-Cappa F, Gramenzi A, Santi V, et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut, 2010,59 : 387-396.
  • 3程树群,吴孟超.原发性肝癌综合治疗进展[J].中华肝胆外科杂志,2009,15(4):241-243. 被引量:31
  • 4Kapoor R, Sakai LY, Funk S, et al. Type Ⅷ collagen has a restricted distribution in specialized extracellular matrices. J Cell Biol, 1988,107:721-730.
  • 5Koon N, Schneider-Stock R, Sarlomo-Rikala M, et al. Molecular targets for turnout progression in gastrointestinal stromal tumours. Gut, 2004,53:235-240.
  • 6Xu R, Yao ZY, Xin L, et al. NC1 domain of human type Ⅷ collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Biochem Biophys Res Commun, 2001,289:264-268.
  • 7Tanaka S, Arii S. Current status and perspective of antiangiogenie therapy for cancer: hepatocellular carcinoma. Int J Clin Oncol, 2006,11 : 82-89.
  • 8Hou G, Mulholland D, Gronska, MA, et al. Type Ⅷ collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am J Pathol, 2000, 156: 467-476.

二级参考文献22

  • 1程树群,吴孟超,陈汉,杨家和,丛文铭,王培军,赵玉祥.外科综合治疗对肝细胞癌合并门静脉癌栓的疗效观察[J].中华肝胆外科杂志,2004,10(10):662-664. 被引量:7
  • 2吴孟超,程树群.肝癌微创外科治疗的现状和展望[J].中国微创外科杂志,2005,5(2):85-87. 被引量:37
  • 3程树群,吴孟超.肝癌门静脉癌栓临床研究进展和展望[J].中国微创外科杂志,2007,7(1):6-7. 被引量:19
  • 4Wang Y, Chen H, Wu MC, et al. Surgical resection of right or total caudate lobe of the liver including the paracaval portion. Chin-Ger J Clin Oncol, 2003,2 :14-17.
  • 5Zhang ZJ, Liu Q, He J, et al. The effect of preoperative transcatheter hepatic arterial chemoembolization disease-free survival after hepatectomy for hepatoeellular carcinoma. Cancer, 2000,89 : 2606-2612.
  • 6Cheng SQ, Wu MC, Chen H, et al. Combination transcatheter hepatic arterial chemoembolization with thymosin al on prevention recurrence of hepatocellular carcinoma after hepatectomy. Hepatogastroenterology,2004, 51:1445-1447.
  • 7Komorizono Y, Kohara K, Oketani M, et al. Systemic combined chemotherapy with low dose of 5-fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol,2003, 21: 421-427.
  • 8Lencioni A, Allgaier C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology,2003, 228 : 235-240.
  • 9Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radiofequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology, 2000, 217: 119-126.
  • 10Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54: 499-502.

共引文献30

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部